Home › Cases › Sickle Cell — Stroke and Neurological
Sickle Cell Crisis
Sickle Cell — Stroke and Neurological
6 questions
Question 1 · Stroke in SCD
Correct answer: Urgent exchange transfusion: target HbS <30%. Emergency CT head. IV fluids. Thrombolysis relatively contraindicated in SCD stroke (sickling mechanism, not thrombus)
Why
SCD stroke: exchange transfusion is the emergency treatment — reduces HbS rapidly, improves oxygenation, reduces blood viscosity. CT head urgently (exclude haemorrhage before exchange). Thrombolysis: controversial/relatively contraindicated in SCD ischaemic stroke (sickling mechanism, not cardioembolism). Children with SCD: stroke incidence 10% by age 20.
Key point
SCD stroke: emergency exchange transfusion (HbS <30%). CT head to exclude haemorrhage. Thrombolysis not first-line. 10% SCD children stroke by age 20.
Question 2 · Transcranial Doppler
Correct answer: Transcranial Doppler ultrasound (TCD): annual screening from age 2. Time-averaged mean of maximum velocity (TAMMX) >200 cm/s = high stroke risk → chronic transfusion
Why
TCD screening (STOP trial): annual TCD in children with HbSS from age 2. TAMMX >200 cm/s = abnormal (high stroke risk). STOP trial: chronic blood transfusion programme reduces stroke by 90% in high-risk children. Current UK guidance: annual TCD from age 2-16. If abnormal: chronic transfusion programme or hydroxycarbamide.
Key point
TCD screening: annual in SCD children age 2-16. TAMMX >200 = high risk. Chronic transfusion reduces stroke 90% (STOP trial).
Question 3 · Posterior reversible encephalopathy
Correct answer: PRES (Posterior Reversible Encephalopathy Syndrome): hypertension + vasogenic oedema in posterior circulation. Seen in SCD with severe hypertension or exchange transfusion complications
Why
PRES in SCD: dysregulation of cerebral vascular autoregulation → vasogenic oedema predominantly in posterior cortex. Triggers: hypertension, exchange transfusion (citrate → hypocalcaemia → hypertension), immunosuppressants. MRI: bilateral occipital T2 signal. Treatment: control BP, stop trigger, antiepileptics. Usually reversible with treatment.
Key point
PRES in SCD: bilateral occipital T2 signal on MRI, hypertension, seizures. Triggered by BP or exchange transfusion. Usually reversible.
Question 4 · Moyamoya disease
Correct answer: Moyamoya disease: progressive large vessel occlusion in SCD. 'Puff of smoke' = collateral network on angiography. Chronic transfusion + neurosurgical revascularisation (EDAS)
Why
Moyamoya in SCD: progressive stenosis of circle of Willis vessels, particularly ICA bifurcation and MCA. Collateral vessels develop ('puff of smoke' = moyamoya in Japanese). High stroke recurrence. Management: chronic blood transfusion programme (reduces HbS → reduces sickling-related vessel damage). Neurosurgical revascularisation: EDAS (encephaloduroarteriosynangiosis).
Key point
Moyamoya in SCD: progressive ICA/MCA stenosis + puff of smoke collaterals. Chronic transfusion + EDAS revascularisation.
Question 5 · Headache in SCD
Correct answer: Intracranial haemorrhage (particularly subarachnoid — high risk from aneurysms in SCD), stroke, meningitis (hyposplenic), PRES. CT head ± LP
Why
Headache in SCD: never dismiss as 'typical'. Differentials:
- subarachnoid haemorrhage (SCD aneurysm prevalence increased)
- intracranial haemorrhage (haemorrhagic stroke risk — worse prognosis than ischaemic)
- ischaemic stroke
- meningitis (functional asplenia)
- PRES
All require CT head urgently. LP if CT normal and SAH suspected.
Key point
Headache in SCD: urgent CT head. Exclude SAB (aneurysm risk), haemorrhagic stroke, meningitis, PRES. Never dismiss as migraine.
Question 6 · SCD in pregnancy
Correct answer: Increased: painful crises, ACS, pre-eclampsia, preterm labour, IUGR, VTE, maternal death. Manage in combined SCD + obstetric clinic. Hydroxycarbamide must be stopped before conception
Why
SCD in pregnancy: high-risk — increased painful crises, ACS risk (respiratory changes in pregnancy), pre-eclampsia (4x increased), preterm birth, IUGR, VTE, perinatal loss. Monitoring: combined haematology + obstetric clinic, fortnightly from 12 weeks. Hydroxycarbamide: teratogenic — stop pre-conception. Folic acid 5mg. LMWH (VTE). Prophylactic transfusion in some centres.
Key point
SCD pregnancy: increased crises, ACS, pre-eclampsia, IUGR, VTE. Stop hydroxycarbamide before conception. Combined specialist clinic.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.